These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25670024)

  • 1. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain.
    Fazzari J; Lin H; Murphy C; Ungard R; Singh G
    Sci Rep; 2015 Feb; 5():8380. PubMed ID: 25670024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain.
    Ungard RG; Seidlitz EP; Singh G
    Pain; 2014 Jan; 155(1):28-36. PubMed ID: 23999057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.
    Slosky LM; BassiriRad NM; Symons AM; Thompson M; Doyle T; Forte BL; Staatz WD; Bui L; Neumann WL; Mantyh PW; Salvemini D; Largent-Milnes TM; Vanderah TW
    Pain; 2016 Nov; 157(11):2605-2616. PubMed ID: 27482630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and cancer pain.
    Ungard RG; Seidlitz EP; Singh G
    Can J Physiol Pharmacol; 2013 Jan; 91(1):31-7. PubMed ID: 23368277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of capsazepine as a novel inhibitor of system x
    Fazzari J; Balenko MD; Zacal N; Singh G
    J Pain Res; 2017; 10():915-925. PubMed ID: 28458574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat.
    Harte M; O'Connor WT
    Brain Res; 2004 Aug; 1017(1-2):120-9. PubMed ID: 15261107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer cell lines release glutamate into the extracellular environment.
    Seidlitz EP; Sharma MK; Saikali Z; Ghert M; Singh G
    Clin Exp Metastasis; 2009; 26(7):781-7. PubMed ID: 19526315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate enrichment as new diagnostic opportunity in breast cancer.
    Budczies J; Pfitzner BM; Györffy B; Winzer KJ; Radke C; Dietel M; Fiehn O; Denkert C
    Int J Cancer; 2015 Apr; 136(7):1619-28. PubMed ID: 25155347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
    Singh K; Munuganti RS; Leblanc E; Lin YL; Leung E; Lallous N; Butler M; Cherkasov A; Rennie PS
    Breast Cancer Res; 2015 Feb; 17(1):27. PubMed ID: 25848700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of phosphatidylinositol-linked D1-like receptors increases spontaneous glutamate release in rat somatosensory cortical neurons in vitro.
    Chu HY; Yang Z; Zhao B; Jin GZ; Hu GY; Zhen X
    Brain Res; 2010 Jul; 1343():20-7. PubMed ID: 20420815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of spinal neuregulin 1-ErbB2 signaling pathway in a rat model of cancer-induced bone pain.
    Jiang J; Zhang J; Yao P; Wu X; Li K
    Int J Oncol; 2014 Jul; 45(1):235-44. PubMed ID: 24818668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain.
    Chen L; Zhu L; Wang K; Wang W; Mei XP; Liu T; Zhang FX; Wang W; Chen T; Li YQ
    Pain Physician; 2013; 16(6):533-46. PubMed ID: 24284839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Phosphatidylinositol-Linked Dopamine Receptors Induces a Facilitation of Glutamate-Mediated Synaptic Transmission in the Lateral Entorhinal Cortex.
    Glovaci I; Chapman CA
    PLoS One; 2015; 10(7):e0131948. PubMed ID: 26133167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nNav1.5 expression is associated with glutamate level in breast cancer cells.
    Azahar II; Sharudin NA; Noor Din AHM; Che Has AT; Mohd Nafi SN; Jaafar H; Mokhtar NF
    Biol Res; 2022 Apr; 55(1):18. PubMed ID: 35488278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cells release glutamate via the cystine/glutamate antiporter.
    Sharma MK; Seidlitz EP; Singh G
    Biochem Biophys Res Commun; 2010 Jan; 391(1):91-5. PubMed ID: 19896463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
    Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation.
    Mastro AM; Gay CV; Welch DR; Donahue HJ; Jewell J; Mercer R; DiGirolamo D; Chislock EM; Guttridge K
    J Cell Biochem; 2004 Feb; 91(2):265-76. PubMed ID: 14743387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
    Farabegoli F; Vettraino M; Manerba M; Fiume L; Roberti M; Di Stefano G
    Eur J Pharm Sci; 2012 Nov; 47(4):729-38. PubMed ID: 22954722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
    Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.